Surface Oncology, Inc.
SEC CIK 1718108 · SURF · last insider filing 2023-09-08
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Goater Jeff | Director · Chief Executive Officer | filed 2018 - 2023 |
| Sigal Charles Elliott | Director | filed 2018 - 2023 |
| Grayzel David S. | Director | filed 2018 - 2023 |
| Ross Robert W. | Director · Chief Medical Officer | filed 2018 - 2023 |
| Brunn Carsten | Director | filed 2022 - 2022 |
| Stelzer Laurie | Director | filed 2018 - 2022 |
| Shanafelt Armen | Director | filed 2018 - 2022 |
| Hickey Benjamin | Director | filed 2021 - 2022 |
| Ibrahim Ramy | Director | filed 2019 - 2022 |
| Torres Denice | Director | filed 2021 - 2022 |
| Mcdonough Geoff | Director | filed 2018 - 2021 |
| Lynch Daniel | Director | filed 2018 - 2020 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Oneill Alison | Chief Medical Officer | filed 2021 - 2023 |
| Palombella Vito J. | Chief Scientific Officer | filed 2018 - 2023 |
| Fees Jessica | See Remarks | filed 2018 - 2023 |
| Rath Henry C. | Chief Business Officer | filed 2021 - 2023 |
| Adams Chandra | Deputy GC | filed 2022 - 2023 |
| Boni Theresa | General Counsel & Secretary | filed 2022 - 2022 |
| Nogelo Liisa I | General Counsel | filed 2018 - 2022 |
| Dwyer Wendy | Chief Business Officer | filed 2019 - 2020 |
| Chappel Scott C | Chief Technology Officer | filed 2018 - 2018 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.